Last updated on September 2017

Xeltis Bioabsorbable Pulmonary Valved Conduit Early Feasibility Study


Brief description of study

This is a multi-center prospective, single-arm, non-randomized, open label study to assess feasibility of the Xeltis Bioabsorbable Pulmonary Valved Conduit in subjects requiring Right Ventricular Outflow Tract correction or reconstruction due to congenital heart malformations.

Clinical Study Identifier: NCT03022708

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Kirk Kanter, MD

Children's Healthcare of Atlanta
Atlanta, GA United States
  Connect »

Christopher Baird, MD

Boston Children's Hospital
Boston, MA United States
  Connect »

Emile Bacha

New York Presbyterian Hospital - Columbia University
New York, NY United States
  Connect »

J William Gaynor, MD

The Children's Hospital of Philadelphia
Philadelphia, PA United States
  Connect »